Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

TDOC holding history

Teladoc Health, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TDOC overviewAll 13F holders of TDOCFull Q2 2026 holdings

Shares (Q2 2026)
2,052,026
Value
$17.4M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of TDOC by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20262,052,026$17.4M<0.1%+325,203+18.8%AddedHolders
Q1 20261,726,823$9.41M<0.1%+228,272+15.2%AddedHolders
Q4 20251,498,551$10.5M<0.1%+296,767+24.7%AddedHolders
Q3 20251,201,784$9.29M<0.1%+198,647+19.8%AddedHolders
Q2 20251,003,137$8.74M<0.1%−412,799−29.2%ReducedHolders
Q1 20251,415,936$11.3M<0.1%+395,177+38.7%AddedHolders
Q4 20241,020,759$9.28M<0.1%−36,151−3.4%ReducedHolders
Q3 20241,056,910$9.70M<0.1%−456,423−30.2%ReducedHolders
Q2 20241,513,333$14.8M<0.1%+591,946+64.2%AddedHolders
Q1 2024921,387$13.9M<0.1%+403,889+78.0%AddedHolders
Q4 2023517,498$11.2M<0.1%−94,640−15.5%ReducedHolders
Q3 2023612,138$11.4M<0.1%+137,939+29.1%AddedHolders
Q2 2023474,199$12.0M<0.1%−33,906−6.7%ReducedHolders
Q1 2023508,105$13.2M<0.1%−671,960−56.9%ReducedHolders
Q4 20221,180,065$27.9M<0.1%−201,803−14.6%ReducedHolders
Q3 20221,381,868$35.0M<0.1%+377,694+37.6%AddedHolders
Q2 20221,004,174$33.3M<0.1%+624,353+164.4%AddedHolders
Q1 2022379,821$27.4M<0.1%−304,106−44.5%ReducedHolders
Q4 2021683,927$62.8M<0.1%+258,100+60.6%AddedHolders
Q3 2021425,827$54.0M<0.1%−245,381−36.6%ReducedHolders
Q2 2021671,208$111.6M<0.1%+77,582+13.1%AddedHolders
Q1 2021593,626$107.9M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.